Future Perspectives in Anti-Angiogenic Therapy for Advanced Stage and Adjuvant CRC Lee M. Ellis, MD Departments of Cancer Biology and Surgical Oncology.
Novel Biologic Therapies for Second-Line Gastric Cancer
Novel Biologic Therapies for Second-Line Gastric Cancer Charles S. Fuchs, MD Dana-Farber Cancer Institute Harvard Medical School Boston, MA.
Encore1 study design
